Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 GP91 | DOI: 10.1530/endoabs.41.GP91

ECE2016 Guided Posters Diabetes (2) (10 abstracts)

Relationship between urinary metabolites and type 2 diabetes mellitus by proton nuclear magnetic resonance spectroscopy method (1H-NMR)

Lorena Ivona Stefan 1, , Alina Nicolescu 2 , Simona Popa 3, , Magda Sandu 3 , Maria Mota 3, , Eugenia Kovacs 5 & Calin Deleanu 2,


1County Clinical Emergency Hospital, Department of Clinical Chemistry and Laboratory Medicine, Craiova, Romania; 2Petru Poni Institute of Macromolecular Chemistry, Group of Biospectroscopy, Iasi, Romania; 3County Clinical Emergency Hospital, Department of Diabetes, Nutrition and Metabolic Diseases, Craiova, Romania; 4Department of Diabetes, Nutrition and Metabolic Diseases, University of Medicine and Pharmacy, Craiova, Romania; 5Department of Medical Biophysics, University of Medicine and Pharmacy, Bucharest, Romania; 6C.D.Nenitescu Institute of Organic Chemistry, Group of Biospectroscopy, Bucharest, Romania.


Proton nuclear magnetic resonance spectroscopy (1H-NMR) was applied to investigate metabolic profile of type 2 diabetes mellitus (T2DM) patients and identify possible disorders of T2DM.

We investigate the potential relationship between diabetic retinopathy (DR), diabetic neuropathy (DN), estimated glomerular filtration rate (eGFR), anthropometric indicators (body mass index (BMI), waist circumference (WC), waist to hip ratio (WHR), waist to stature ratio (WSR)), HbA1c (%) levels and urinary metabolites in T2DM patients.

Serial urine samples of 334 healthy subjects and 388 T2DM patients with a history of diabetes <5 years were investigated by 1H-NMR. The 1H-NMR spectra have been recorded on a Bruker Avance DRX 400 MHz spectrometer. The results are evaluated in mmol/mol of creatinine.

A significant difference between the urinary excretion of valine (P=0.007), alanine (P<0.0001), γ-aminobuthyrate (P=0.001), betaine (P=0.036), citric acid (P<0.0001), trimethylamine-N-oxide (P<0.0001) and glycine (P<0.0001) at the healthy individuals and T2DM patients was found. The values for 3-hydroxyisolateric acid (P=0.042), citrate (P=0.019) and γ-aminobuthyrate (P=0.037) increase in T2DM patients with retinopathy vs without retinopathy. There was no correlation between DN and urinary metabolite picture in T2DM patients. We found significant correlation between eGFR and dimethylamine (r=0.194, P=0.031), gamma-aminobuthyrate (r=0.239, P=0.049), acetate (r=0.29, P=0.035) and pyruvate (r=0.275, P=0.014) in T2DM patients. Our analysis revealed significant decreased concentrations for citrate (P=0.005), dimethylamine (P=0.013) and glycine (P=0.009) in T2DM patients with the increase of BMI. WC were positively correlated with gamma-aminobuthyrate (r=0.42, P=0.01) and dimethylamine (r=0.39, P=0.03) and, no correlation were observed between WHR, WSR and urinary metabolites in T2DM patients. Alanine (P=0.003), lactate (P=0.015) and 3-hydroxyisovaleric acid (P=0.006) increased with the increase of HbA1c levels.

Type 2 DM urinary metabolites are interesting in various aspects, such as providing clues for the mechanisms of the disease or potential early markers in diabetes.

Article tools

My recent searches

No recent searches.